More than 305,000 high-resolution, multi-channel COVID-19 cellular images captured in less than four weeks with Molecular Devices ImageXpress® Micro Confocal High-Content Imaging System are now available to the scientific community.

Atelerix has announced the appointment of two experienced industry executives, who will help lead Atelerix in implementing its strategy to provide room temperature solutions for the shipping of therapeutic cells in the fast growing cellular therapy market.

NanoImaging Services, Inc. has announced the opening of a new facility to support its growing customer base requiring cryoEM for drug discovery and vaccine development applications. COVID-19 projects are receiving prioritization.

Sermo has released new physician insights into the future of tackling Alzheimer's disease.

Dotmatics Ltd. has announced that it has entered into an agreement to acquire BioBright LLC, aiming to create a unique combination of lab data capture, data processing, electronic lab notebook (ELN) and data analytics capability from a single supplier.

An advanced laboratory dedicated to leading Wales’ national COVID-19 testing has been established in Cardiff, thanks to collaboration between Public Health Wales and one of the world’s leading diagnostics companies.

In a strategic new alignment, Van Heron Labs and Foresight Biosciences will take aim at surpassing the boundaries in a burgeoning field: biotechnology.

The collaboration will allow Bristol Myers Squibb to capitalize on the strength and breadth of Ubiquigent’s deubiquitylase (DUB) enzyme inhibitor drug discovery platform and expertise.

Codexis, Inc., a leading protein engineering company and developer of high-performance enzymes, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announce a partnership to engineer enzymes to deliver differentiated and cost-effective solutions for the enzymatic synthesis of DNA.

Avacta has announced that the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed, evaluated and show positive initial performance data.